Immunomedics, Inc. (IMMU) financial statements (2021 and earlier)

Company profile

Business Address 300 AMERICAN RD
MORRIS PLAINS, NJ 07950
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
9/30/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments976541613369433443586
Cash and cash equivalents971536609365428438581
Short-term investments4455555
Receivables22 0    
Inventory, net of allowances, customer advances and progress billings21      
Inventory21      
Prepaid expense211722885 
Other current assets4431118
Total current assets:1,043562639378442449594
Noncurrent Assets
Property, plant and equipment34323333353519
Other noncurrent assets0000000
Total noncurrent assets:34323334353619
TOTAL ASSETS:1,077594672412478485613
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:60596155395434
Accounts payable  38    
Accrued liabilities      4
Employee-related liabilities  7    
Other undisclosed accounts payable and accrued liabilities60591655395429
Debt 07    
Other undisclosed current liabilities217336310
Total current liabilities:81677258455744
Noncurrent Liabilities
Long-term debt and lease obligation10101077720
Long-term debt, excluding current maturities   77720
Operating lease, liability101010   
Liabilities, other than long-term debt12665757575102
Deferred revenue1266565   
Contract with customer, liability6565 
Other liabilities  101010102
Other undisclosed noncurrent liabilities268267248248236229207
Total noncurrent liabilities:404342333330319246229
Total liabilities:485409404388363303273
Stockholders' equity
Stockholders' equity attributable to parent59318626824116183344
Common stock2222222
Treasury stock, value(2)(2)(2)(2)(2)(2)(1)
Additional paid in capital2,0641,5901,5791,2361,2331,2241,203
Accumulated other comprehensive loss(1)(1)(1)(1)(0)(1)(0)
Accumulated deficit(1,470)(1,403)(1,310)(1,211)(1,117)(1,041)(860)
Stockholders' equity attributable to noncontrolling interest(1)(1)(1)(1)(1)(1)(4)
Total stockholders' equity:59218526723115182339
TOTAL LIABILITIES AND EQUITY:1,077594672412478485613

Income statement (P&L) ($ in millions)

6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
9/30/2018
Q1
Revenues20 0    
Cost of revenue
(Cost of Goods and Services Sold)
(2)      
Gross profit:18      
Operating expenses(71)(82)(92)(87)(67)(80)(57)
Other undisclosed operating income  0    
Operating loss:(53)(82)(91)(87)(67)(80)(57)
Interest and debt expense(14)(14)(10)(10)(11)(10)(10)
Loss from continuing operations before equity method investments, income taxes:(67)(96)(101)(97)(78)(90)(67)
Other undisclosed income from continuing operations before income taxes1222223
Net loss:(66)(93)(100)(94)(76)(87)(64)
Net income attributable to noncontrolling interest0000 00
Net loss available to common stockholders, diluted:(66)(93)(100)(94)(76)(87)(64)

Comprehensive Income ($ in millions)

6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
9/30/2018
Q1
Net loss:(66)(93)(100)(94)(76)(87)(64)
Other comprehensive income (loss)0(0)0(0)0(0)0
Comprehensive loss:(66)(93)(100)(95)(76)(88)(64)
Comprehensive income, net of tax, attributable to noncontrolling interest0000 00
Comprehensive loss, net of tax, attributable to parent:(66)(93)(100)(95)(76)(88)(64)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: